• Home
  • Paras Biopharmaceuticals Finland Oy

Paras Biopharmaceuticals Finland Oy

About Paras Biopharmaceuticals Finland Oy

Company activities & offerings are categorized in 3 major areas:

1. Contract development & microbial biologics manufacturing (CDMO):The company offers end-to-end services for production of microbial recombinant proteins. 

2. Development of Recombinant expression systems and process technologies for biologics and biosimilars: Recombinant IL1-RA / Anakinra (Kineret® Biosimilar) and Recombinant Romiplostim (Nplate® Biosimilar).

3. Recombinant Bioprocess Enzymes:  offering Enterokinase & TEV Protease.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • FI
  • 2018
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Paras Biopharmaceuticals Finland Oy (5)

  • Anakinra Biosimilar Candidate

    Product Anakinra Biosimilar Candidate

    Paras Biopharmaceuticals has been intensively working on a Anakinra / IL1-RA biosimilar known as Kineret™) and has progressively achieved success. The company plans to mature good value within its Anakrina / IL1-RA asset and would like to highlight the following points / highlights to gauge your level of ...
  • RapidEK® (Recombinant Enterokinase)

    Product RapidEK® (Recombinant Enterokinase)

    Paras Biopharma has developed and is offering Recombinant Bioprocess enzymes. This includes Recombinant Enterokinase (RapidEK®). As a type 2 transmembrane serine protease, enterokinase is ideally suited for the biotechnological and biochemical removal of fusion proteins and cleavage of tags after purifica...
  • RapidTEV® Protease (Recombinant TEV Protease)

    Product RapidTEV® Protease (Recombinant TEV Protease)

    Paras Biopharma has developed and is offering Recombinant Bioprocess enzymes including Recombinant Tev Protease (RapidTEV®). RapidTEV® Protease is a site-specific protease that has been engineered for enhanced activity and greater stability. Due to its high specificity it is frequently used for the clea...
  • Rasburicase Biosimilar candidate

    Product Rasburicase Biosimilar candidate

    Paras Biopharmaceuticals has been intensively working on a Romiplostim biosimilar known as Elitek™ / Fasturtec™) and has progressively achieved success. The company plans to mature good value within its Rasburicase asset and would like to highlight the following points / highlights to gauge your level of ...
  • Romiplostim Biosimilar Candidate

    Product Romiplostim Biosimilar Candidate

    Due to the complex nature of the product, Paras Biopharmaceuticals has been intensively working on this complex drug (Nplate™) for over 6 years and has progressively achieved success. The company plans to mature good value within its Romiplostim asset (Biosimilar) and would like to highlight the following...